Flow Cytometry Core

流式细胞术核心

基本信息

  • 批准号:
    10452734
  • 负责人:
  • 金额:
    $ 16.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The Flow Cytometry Core (Core B) has four major goals. Its primary function is to provide state of the art equipment and expertise for flow cytometric analysis of cellular antigen expression, function, metabolism and signaling thereby supporting cardiovascular research in diabetes and obesity at the University of Louisville. Core B personnel are highly-experienced investigators who have worked for several years on flow cytometry using various tissues and cells from multiple species and have extensive expertise in rare event analysis. The complementary nature of their backgrounds and areas of expertise, coupled with their collegial nature, provides a strong foundation for productive synergy within this Core and its productive interactions with other investigators in the DOC, at the UofL and with collaborative interactions with other Institutes. Secondly, the Core is committed to an educational goal. Not only will all users be trained on the operation of instruments, it is the intent that these users completely understand cytometric theory, application, and data analysis. Through hands-on training and educational presentations, it is hoped that all current and future users will be able to competently incorporate flow cytometry as an analytical tool. Third, the Core is committed to developing its scope and operation to support multidimensional flow cytometry needs in the future. It will continue to upgrade its equipment and analytical repertoire. Finally, this Core has the ultimate goal of developing into a self-supporting and large-scale flow cytometry operation that will cater not only to the specific needs of the Center but to other University and extramural investigators interested in diabetes and obesity research. A fully developed Flow Cytometry Core will be a significant asset in developing future multi-investigator projects and for helping researchers conduct multifaceted basic and clinical investigations aimed at the amelioration of health hazards caused by diabetes and obesity.
摘要 流式细胞术核心(核心B)有四个主要目标。其主要功能是提供最先进的 用于流式细胞术分析细胞抗原表达、功能、代谢和功能的设备和专业知识 信号,从而支持路易斯维尔大学的糖尿病和肥胖症的心血管研究。核心 B人员是经验丰富的研究人员,他们在流式细胞术方面工作了数年, 来自多个物种的各种组织和细胞,并在罕见事件分析方面拥有丰富的专业知识。的 他们的背景和专业领域的互补性,加上他们的合议性质, 在本核心内进行富有成效的协同作用以及与其他研究人员进行富有成效的互动的坚实基础 在DOC,在UofL和与其他研究所的合作互动。第二,核心承诺 to an educational教育goal目标.不仅所有用户都将接受仪器操作培训, 用户完全了解细胞计数理论、应用和数据分析。通过实践培训, 教育介绍,希望所有当前和未来的用户将能够胜任地纳入 流式细胞术作为分析工具。第三,核心致力于发展其范围和业务,以支持 流式细胞仪在未来的需求。它将继续更新其设备和分析 保留曲目。最后,这个Core的最终目标是发展成为一个自收自支的大流量 细胞计数操作,不仅满足中心的具体需求,而且满足其他大学和 对糖尿病和肥胖症研究感兴趣的校外研究人员。完全开发的流式细胞术核心 将是开发未来多研究者项目和帮助研究人员进行 旨在改善糖尿病引起的健康危害的多方面基础和临床研究 和肥胖。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy E O'Toole其他文献

Timothy E O'Toole的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy E O'Toole', 18)}}的其他基金

Flow Cytometry Core
流式细胞术核心
  • 批准号:
    10208900
  • 财政年份:
    2018
  • 资助金额:
    $ 16.22万
  • 项目类别:
Metabolism and Toxicity Core
代谢和毒性核心
  • 批准号:
    10354696
  • 财政年份:
    2017
  • 资助金额:
    $ 16.22万
  • 项目类别:
Metabolism and Toxicity Core
代谢和毒性核心
  • 批准号:
    10693820
  • 财政年份:
    2017
  • 资助金额:
    $ 16.22万
  • 项目类别:
Core C: Cardiovascular Pathology Core
核心 C:心血管病理学核心
  • 批准号:
    8595398
  • 财政年份:
    2013
  • 资助金额:
    $ 16.22万
  • 项目类别:
CENTER OF EXCELLENCE IN DIABETES AND OBESITY RESEARCH: PROJECT 1
糖尿病和肥胖研究卓越中心:项目 1
  • 批准号:
    8360414
  • 财政年份:
    2011
  • 资助金额:
    $ 16.22万
  • 项目类别:
CENTER OF EXCELLENCE IN DIABETES AND OBESITY RESEARCH: PROJECT 1
糖尿病和肥胖研究卓越中心:项目 1
  • 批准号:
    8168209
  • 财政年份:
    2010
  • 资助金额:
    $ 16.22万
  • 项目类别:
CENTER OF EXCELLENCE IN DIABETES AND OBESITY RESEARCH: PROJECT 1
糖尿病和肥胖研究卓越中心:项目 1
  • 批准号:
    7960462
  • 财政年份:
    2009
  • 资助金额:
    $ 16.22万
  • 项目类别:
Core B- Expression
核心B-表达
  • 批准号:
    6853219
  • 财政年份:
    2004
  • 资助金额:
    $ 16.22万
  • 项目类别:
PHYSIOLOGICAL MECHANISMS OF INTEGRIN AFFINITY MODULATION
整合素亲和力调节的生理机制
  • 批准号:
    2231641
  • 财政年份:
    1995
  • 资助金额:
    $ 16.22万
  • 项目类别:
PHYSIOLOGICAL MECHANISMS OF INTEGRIN AFFINITY MODULATION
整合素亲和力调节的生理机制
  • 批准号:
    2231642
  • 财政年份:
    1995
  • 资助金额:
    $ 16.22万
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 16.22万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
  • 批准号:
    10334113
  • 财政年份:
    2022
  • 资助金额:
    $ 16.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了